Q5W-17985-66554
1 vaccination
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- Native Hawaiian or other Pacific Islander
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches · Be unable to workAdult check-in
- 2021-01-14
- 2021-01-16
- 2021-01-18
-
2021-02-12
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-07-14
-
2022-01-13
Survey response — 12 months, dose 1MedDRA: Cough, Fatigue, Headache, Myalgia, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose, fever, fatigue, muscle and headache, coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 10 — 12 months, dose 1
Symptoms: Runny nose, fever, fatigue, muscle and headache, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release